TimeMon-Sat 9.00 AM - 6.00 PM
RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML

RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML

32675.58 INR/Pack

Product Details:

  • Indication Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis
  • Dosage Form Concentrate for Solution for Infusion
  • Salt Composition Rituximab 10mg/ml
  • Enzyme Types Not applicable (Monoclonal antibody, not an enzyme)
  • Feature Ready-to-dilute sterile concentrate; preservative free; for hospital/institutional use
  • Ingredients Rituximab, Polysorbate 80, Sodium Chloride, Sodium Citrate, Citric Acid, Water for Injection
  • Application Intravenous infusion for cancer and autoimmune disorders
  • Click to view more
X

RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML Price And Quantity

  • 32675.58 INR/Pack
  • 100 Pack
  • 500mg/50ml or 100mg/10ml
  • Glass vial with rubber stopper
  • For use by registered medical practitioners or hospitals only
  • Produced by recombinant DNA technology
  • Intravenous only
  • Rx (Prescription only)
  • Must be diluted with 0.9% Sodium Chloride prior to administration

RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML Product Specifications

  • Rituximab, Polysorbate 80, Sodium Chloride, Sodium Citrate, Citric Acid, Water for Injection
  • Not applicable (Monoclonal antibody, not an enzyme)
  • Concentrate for Solution for Infusion
  • 24 months (Unopened vial)
  • Not applicable (biotechnological production, not classical fermentation)
  • Clear to slightly opalescent, colorless to pale yellow liquid
  • Intravenous infusion for cancer and autoimmune disorders
  • 6.5 - 7.0 (approximate)
  • AS PER INSTRUCTIONS
  • Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis
  • Rituximab 10mg/ml
  • Ready-to-dilute sterile concentrate; preservative free; for hospital/institutional use
  • 500mg/50ml or 100mg/10ml
  • Glass vial with rubber stopper
  • For use by registered medical practitioners or hospitals only
  • Produced by recombinant DNA technology
  • Intravenous only
  • Rx (Prescription only)
  • Must be diluted with 0.9% Sodium Chloride prior to administration

RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML Trade Information

  • AHEMDABAD, MUNDRA & MUMBAI
  • 1000 Pack Per Month
  • 2 Week
  • FOR SINGLE DOSE VIAL
  • AS PER AVAILABILITY

Product Description

PRODUCT NAME:iRITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/M

GENERIC NAME:iRITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML

MANUFACTURER: OCEAN

PACKING: SINGLE DOSE VIAL


USES:iRituximab is used to treat certain types of cancer (such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia). It works by slowing or stopping the growth of cancer cells.

Some brands of rituximab are also used to treat rheumatoid arthritis and can decrease joint pain and swelling. This drug is also used to treat certain types of blood vessel disease (such as granulomatosis with polyangiitis, microscopic polyangiitis) and can decrease the swelling of the blood vessels. Rituximab is also used to treat a certain skin condition (pemphigus vulgaris). It helps to reduce the number of skin lesions.




Advanced Monoclonal Antibody Therapy

Rituximab delivers targeted treatment for certain cancers and autoimmune disorders. By targeting CD20-positive cells, it can help reduce disease activity and improve patient outcomes. The product is ideal for use in hospital and institutional settings under careful supervision.


Strict Quality Standards and Ready-to-Use Packaging

Manufactured in India using modern recombinant DNA technology, each vial is quality-tested and sterile. It is preservative-free and comes ready for dilution. Practitioners can expect clear to slightly opalescent, colorless to pale yellow liquid with a pH close to physiological values.


Comprehensive Application and Preparation Guidelines

Rituximab concentrate must be diluted with 0.9% Sodium Chloride before use, guaranteeing safety and correct dosing. Only registered medical practitioners should administer this intravenously, following prescription and dosage guidelines specific to each indication.

FAQ's of RITUXIMAB CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML:


Q: How should Rituximab Concentrate for Solution for Infusion 10mg/ml be prepared and administered?

A: Rituximab must be diluted with 0.9% Sodium Chloride before intravenous infusion. The concentrate is not to be administered undiluted and should be handled only by healthcare professionals following aseptic techniques within hospital or institutional environments.

Q: What conditions are treated with Rituximab Concentrate, and who benefits from it?

A: Rituximab is indicated for treatment of Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis. Patients with these cancers or autoimmune disorders may benefit from its targeted therapeutic approach.

Q: When should Rituximab be administered, and what are the dosage guidelines?

A: The timing and dosage for Rituximab administration depend on the specific condition being addressed and are determined by the prescribing physician. All dosage regimens must strictly follow medical instructions provided for the patient's diagnosis.

Q: Where should Rituximab vials be stored prior to use?

A: Unopened Rituximab vials should be stored according to the instructions provided, typically in a controlled environment as specified in the product's storage guidelines, ensuring stability within its 24-month shelf life.

Q: What is the physical appearance of Rituximab Concentrate, and how do you identify it?

A: The concentrate is a clear to slightly opalescent, colorless to pale yellow liquid. Each vial is packaged with a glass container and rubber stopper, ensuring sterility and authenticity.

Q: What are the main benefits of using Rituximab in intravenous infusions?

A: Rituximab provides targeted immune modulation with established efficacy in cancer and autoimmune therapy. Its ready-to-dilute format and absence of preservatives promote safety for hospital or institutional administration, optimizing patient care.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'ANTI CANCER INJECTION' category



Back to top